China Clinical Trial Patient Recruitment Services Market Size & Outlook

The clinical trial patient recruitment services market in China is expected to reach a projected revenue of US$ 94.3 million by 2030. A compound annual growth rate of 9.2% is expected of China clinical trial patient recruitment services market from 2024 to 2030.
Revenue, 2023 (US$M)
$50.9
Forecast, 2030 (US$M)
$94.3
CAGR, 2024 - 2030
9.2%
Report Coverage
China

China clinical trial patient recruitment services market, 2018-2030 (US$M)

China

Related Markets

China clinical trial patient recruitment services market highlights

  • The China clinical trial patient recruitment services market generated a revenue of USD 50.9 million in 2023 and is expected to reach USD 94.3 million by 2030.
  • The China market is expected to grow at a CAGR of 9.2% from 2024 to 2030.
  • In terms of segment, phase iii was the largest revenue generating phase in 2023.
  • Phase I is the most lucrative phase segment registering the fastest growth during the forecast period.


Clinical trial patient recruitment services market data book summary

Market revenue in 2023USD 50.9 million
Market revenue in 2030USD 94.3 million
Growth rate9.2% (CAGR from 2023 to 2030)
Largest segmentPhase iii
Fastest growing segmentPhase I
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPhase I, Phase II, Phase III, Phase IV
Key market players worldwideThermo Fisher Scientific Inc, IQVIA Holdings Inc, Clara Health, Antidote Health, BBK Worldwide, Clariness, Costas Inc, Worldwide Clinical Trials, Veristat, Elligo Health Research


Other key industry trends

  • In terms of revenue, China accounted for 5.6% of the global clinical trial patient recruitment services market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China clinical trial patient recruitment services market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 29.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Clinical Trial Patient Recruitment Services Market Scope

Clinical trial patient recruitment services market segmentation & scope
Phase I
Phase II
Phase III
Phase IV
Patient recruitment & Registry Services
Patient retention
Others
Respiratory Diseases
Pain and Anesthesia
Oncology
Central Nervous System
Cardiovascular
Anti-Infective
Cardiology
CNS
Enodcrine
Pain Mangement
Others
Child (Birth-17 Years)
Adult (18 - 64 Years)
Older Adults (65 Years+)

Clinical Trial Patient Recruitment Services Market Companies

Name Profile # Employees HQ Website

China clinical trial patient recruitment services market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial patient recruitment services market will help companies and investors design strategic landscapes.


Phase iii was the largest segment with a revenue share of 57.37% in 2023. Horizon Databook has segmented the China clinical trial patient recruitment services market based on phase i, phase ii, phase iii, phase iv covering the revenue growth of each sub-segment from 2018 to 2030.


China is one of the major clinical trial markets in the Asia Pacific, owing to the availability of skilled professionals, cost-efficiency, and the growing pharmaceutical industry. According to Globaldata, China accounted for 27.7% of global clinical trials conducted in 2022, which is expected to grow significantly over the forecast period.

Outsourcing of clinical services to China has also increased due to the costefficiency provided by Chinese CROs as compared to that by U.S. and European CROs. For instance, the cost of conducting clinical trials in China is 25% to 40% lower than that of Western countries.

The above factors are expected to improve clinical trials in the country and, thus, support the demand for clinical trial patient recruitment services in China. CR Medicon, a China-based CRO, stated that China is preferred for conducting clinical trials due to its high patient recruitment rate.

Reasons to subscribe to China clinical trial patient recruitment services market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of China clinical trial patient recruitment services market databook

  • Our clientele includes a mix of clinical trial patient recruitment services market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the China clinical trial patient recruitment services market , including forecasts for subscribers. This country databook contains high-level insights into China clinical trial patient recruitment services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

China clinical trial patient recruitment services market size, by phase, 2018-2030 (US$M)

China Clinical Trial Patient Recruitment Services Market Outlook Share, 2023 & 2030 (US$M)

China clinical trial patient recruitment services market size, by phase, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more